Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02346825 · ClinicalTrials.gov registry record · Phase 1
The Baby CHAMP Study (Children With Hemiparesis Arm and Movement Project)
A Phase 1 study, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 58
- Enrollment target
NCT02346825: Completed Phase 1 study, sponsored by Virginia Polytechnic Institute and State University.
NCT02346825 is a Phase 1 study that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 58 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02346825, a Phase 1 study, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 58 participants
- Enrollment target
Study Summary
The Baby CHAMP Study is a multisite clinical trial funded by the National Institutes of Health that is examining the the use of constraint-induced movement therapy (CIMT) for infants and toddlers as a effective treatment, since there have been no randomized control trials (RCT) for the age range as well as monitor the stress levels as related by self-report of parents or biological indicators. Infants and toddlers who meet study eligibility requirements at one of the three clinical sites (Charlottesville, VA, Columbus, OH, and Roanoke, VA) will be invited to enroll, and their parents will be provided all necessary paperwork along with informational documentation.
Primary Outcome
functional assessment
Interventions
- BEHAVIORAL Neurorehabilitation therapy with cast
- BEHAVIORAL Neurorehabilitation therapy with splint
- BEHAVIORAL Neurorehabilitation bimanual
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2015-01 |
| Est. Completion | 2019-12 |
| Phase | Phase 1 |
What the finished NCT02346825 record still lists
NCT02346825 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which Neurorehabilitation therapy with cast is the first listed.
NCT02346825 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02346825 about?
NCT02346825 is a clinical study titled "The Baby CHAMP Study (Children With Hemiparesis Arm and Movement Project)". The Baby CHAMP Study is a multisite clinical trial funded by the National Institutes of Health that is examining the the use of constraint-induced movement therapy (CIMT) for infants and toddlers as a effective treatment, since there have been no randomized control trials (RCT) for the age range as ...
What is the current status of trial NCT02346825?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 58 participants. The study started on 2015-01. Estimated completion is 2019-12.
What interventions are being tested in trial NCT02346825?
The interventions under investigation include: Neurorehabilitation therapy with cast (BEHAVIORAL), Neurorehabilitation therapy with splint (BEHAVIORAL), Neurorehabilitation bimanual (BEHAVIORAL).
Who is sponsoring clinical trial NCT02346825?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02346825's enrollment target sits among peer trials
58 895th of 2000 higher than 1,100 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia